logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
02/02/2026
The director of the Federal Aviation Administration (FAA) of the United States stated that they are still evaluating Boeing's request to increase the monthly production of the 737 MAX to 47 aircraft.
Latest
2 m ago
Goer Shares: Spent 1.108 billion yuan to buy back 1.14% of the company's shares.
3 m ago
Weichai Power: Cumulatively invested 761 million yuan to repurchase 0.58% of A-share shares.
3 m ago
Youxun Co., Ltd.: Open a special settlement account for managing the raised capital of 700 million yuan in cash.
3 m ago
Puran Group: Will consider market supply and production costs for product price adjustments in the future.
4 m ago
Chinese pharmaceutical company: Subsidiary Tianfang Pharmaceuticals obtains registration certificate for Dabigatran Etexilate Capsules.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.